ZOSYN®, an Injectable Antibiotic Combination Product Receives an Approval for Peritonitis, Intra-abdominal Abscess, Cholecystitis, and Cholangitis

The Company's Official Page
http://www.taiho.co.jp/english/news/20120928.html
Back To Previous Page

News Release

September 28, 2012

ZOSYN®, an Injectable Antibiotic Combination Product Receives an Approval for Peritonitis,
Intra-abdominal Abscess, Cholecystitis, and Cholangitis

Taiho Pharmaceutical Co., Ltd. (HQ: Tokyo, President: Masayuki Kobayashi) announced today that ZOSYN® 2.25 and ZOSYN® 4.5 for intravenous injection (generic name: tazobactam and piperacillin for injection), received an approval of new indications for the treatment of peritonitis, intra-abdominal abscess, cholecystitis, and cholangitis in Japan.


Latest News: Pharmaceuticals

    この内容でのリリース掲載はまだ無いか、集計されておりません。

    この内容でのリリース掲載はまだ無いか、集計されておりません。

Most Popular: Pharmaceuticals

1. FDA ACCEPTS FOR REVIEW EISAI'S NDA ...
Eisai Co., Ltd. 2010/06/03
2. HUMIRA Subcutaneous Injection 40mg Syrin...
Eisai Co., Ltd. 2008/06/17
3. Discontinuation of Development of NT-702...
Taisho Pharmaceutical Holdings Co., Ltd. 2009/08/26
4. Investors' Guide 2009
Taisho Pharmaceutical Holdings Co., Ltd. 2009/09/01
5. Eisai Submits Application for Aricept® O...
Eisai Co., Ltd. 2008/03/14

Latest News: Taiho Pharmaceutical Co., Ltd.


Most Popular: Taiho Pharmaceutical Co., Ltd.

1. Taiho Pharmaceutical and Toray Industrie...
2009/03/11

Categories

Go to Page Top

View: Smartphone | PC

Language: English | Japanese

Home

Terms & Conditions

TwitterFacebook

About Us